Galmed Pharmaceuticals Ltd.
Stock Forecast, Prediction & Price Target
Galmed Pharmaceuticals Ltd. Financial Estimates
Galmed Pharmaceuticals Ltd. Revenue Estimates
Galmed Pharmaceuticals Ltd. EBITDA Estimates
Galmed Pharmaceuticals Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
Net Income
% change YoY
| $-31.94M N/A | $-18.57M 41.87% | $-6.91M 62.78% | Avg: $-2.85M Low: $-2.85M High: $-2.85M avg. 58.72% | Avg: $-2.79M Low: $-2.79M High: $-2.79M avg. 1.94% | Avg: $-2.79M Low: $-2.79M High: $-2.79M avg. 0% | |
EBITDA
% change YoY
| $-32.83M N/A | $-17.12M 47.84% | $-6.87M 59.88% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$19.48 N/A | -$11.08 43.12% | -$30.05 -171.20% | Avg: -$1.03 Low: -$1.03 High: -$1.03 avg. 96.57% | Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 1.94% | Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 0% | |
Operating Expenses
% change YoY
| $32.88M N/A | $17.65M -46.31% | $-7.49M -142.44% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Galmed Pharmaceuticals Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.22% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -2.85M, average is -2.85M and high is -2.85M.
What is Galmed Pharmaceuticals Ltd. stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Galmed Pharmaceuticals Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 32.83% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.03, average is -$1.03 and high is $-1.03.